c-Fos oncogene regulator Elk-1 interacts with BRCA1 splice variants BRCA1a/1b and enhances BRCA1a/1b-mediated growth suppression in breast cancer cells

被引:48
|
作者
Chai, YL [1 ]
Chipitsyna, G [1 ]
Cui, JQ [1 ]
Liao, BS [1 ]
Liu, S [1 ]
Aysola, K [1 ]
Yezdani, M [1 ]
Reddy, ESP [1 ]
Rao, VN [1 ]
机构
[1] Med Coll Penn & Hahnemann Univ, Ctr Canc, Dept Med, Program Canc Genet, Philadelphia, PA 19102 USA
关键词
c-Fos; BRCA1/BRCA1a/1b; Elk-1; growth suppression; breast cancer; protein-protein interaction;
D O I
10.1038/sj.onc.1204256
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Elk-1, a c-Fos protooncogene regulator, which belongs to the ETS-domain family of transcriptional factors, plays an important role in the induction of immediate early gene expression in response to a variety of extracellular signals. In this study, we demonstrate for the first time the in, vitro and in vivo interaction of Elk-1 with BRCA1 splice variants BRCA1a and BRCA1b using GST-pull down assays, co-imunoprecipitations/Western blot analysis of cell extracts from breast cancer cells and mammalian two-hybrid assays. We have localized the BRCA1 interaction domain of Elk-1 protein to the conserved ETS domain, a motif involved in DNA binding and protein-protein interactions. We also observed binding of BRCA1 proteins to other ETS-domain transcription factors SAP1, ETS-1, ERG-2 and Fli-1 but not to Elk-1 splice variant Delta Elk-1 and c-Fos protooncogene, Both BRCA1a and BRCA1b splice variants function as growth suppressors of human breast cancer cells. interestingly, our studies reveal that although both Elk-1 and SAP-1 are highly homologous members of a subfamily of ETS domain proteins called ternary complex factors, it is only Elk-1 but not SAP-I that can augment the growth suppressive function of BRCA1a/1b proteins in breast cancer cells, Thus Elk-1 could be a potential downstream target of BRCA1 in its growth control pathway, Furthermore, we hare observed inhibition of c-Fos promoter activity in BRCA1a transfected stable breast cancer cells and over expression of BRCA1a/1b attenuates MEK-induced SRE activation in vivo. These results demonstrate for the first time a link between the growth suppressive function of BRCA1a/1b proteins and signal transduction pathway involving Elk-1 protein, All these results taken together suggest that one of the mechanisms by which BRCA1a/1b proteins function as growth/tumor suppressors is through inhibition of the expression of Elk-1 target genes like c-Fos.
引用
收藏
页码:1357 / 1367
页数:11
相关论文
共 50 条
  • [41] BRCA1 function in breast cancer cells treated by genistein
    Privat, M.
    Aubel, C.
    Arnould, S.
    Bernard-Gallon, D.
    Ferrara, M.
    Bignon, Y. J.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2008, 22 : 38 - 38
  • [42] Location of BRCA1 in human breast and ovarian cancer cells
    Scully, R
    Ganesan, S
    Brown, M
    DeCaprio, JA
    Cannistra, SA
    Feunteun, J
    Schnitt, S
    Livingston, DM
    SCIENCE, 1996, 272 (5258) : 123 - 125
  • [44] Screening of BRCA1/2 variants in Mauritanian breast cancer patients
    Selma Mohamed Brahim
    Ekht Elbenina Zein
    Crystel Bonnet
    Cheikh Tijani Hamed
    Malak Salame
    Mohamed Vall Zein
    Meriem Khyatti
    Ahmedou Tolba
    Ahmed Houmeida
    BMC Cancer, 22
  • [45] Screening of BRCA1/2 variants in Mauritanian breast cancer patients
    Brahim, Selma Mohamed
    Zein, Ekht Elbenina
    Bonnet, Crystel
    Hamed, Cheikh Tijani
    Salame, Malak
    Zein, Mohamed Vall
    Khyatti, Meriem
    Tolba, Ahmedou
    Houmeida, Ahmed
    BMC CANCER, 2022, 22 (01)
  • [46] Concerted transcriptional regulation by BRCA1 and COBRA1 in breast cancer cells
    Aiyar, Sarah E.
    Cho, HyungJun
    Lee, Jae
    Li, Rong
    INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES, 2007, 3 (07): : 486 - 492
  • [47] BRCA1 and BRCA2 germline variants in breast cancer patients from the Republic of Macedonia
    Jakimovska, Milena
    Kostovska, Ivana Maleva
    Popovska-Jankovic, Katerina
    Kubelka-Sabit, Katerina
    Karadjozov, Mitko
    Stojanovska, Liljana
    Arsovski, Andreja
    Smichkoska, Snezhana
    Lazarova, Emilija
    Dimitrovska, Maja Jakimovska
    Plaseska-Karanfilska, Dijana
    BREAST CANCER RESEARCH AND TREATMENT, 2018, 168 (03) : 745 - 753
  • [48] Prevalence of BRCA1 and BRCA2 pathogenic variants in a large, unselected breast cancer cohort
    Li, Jingmei
    Wen, Wei Xiong
    Eklund, Martin
    Kvist, Anders
    Eriksson, Mikael
    Christensen, Helene Nordahl
    Torstensson, Astrid
    Bajalica-Lagercrantz, Svetlana
    Dunning, Alison M.
    Decker, Brennan
    Allen, Jamie
    Luccarini, Craig
    Pooley, Karen
    Simard, Jacques
    Dorling, Leila
    Easton, Douglas F.
    Teo, Soo-Hwang
    Hall, Per
    Borg, Ake
    Gronberg, Henrik
    Czene, Kamila
    INTERNATIONAL JOURNAL OF CANCER, 2019, 144 (05) : 1195 - 1204
  • [49] BRCA1 and BRCA2 germline variants in breast cancer patients from the Republic of Macedonia
    Milena Jakimovska
    Ivana Maleva Kostovska
    Katerina Popovska-Jankovic
    Katerina Kubelka-Sabit
    Mitko Karadjozov
    Liljana Stojanovska
    Andreja Arsovski
    Snezhana Smichkoska
    Emilija Lazarova
    Maja Jakimovska Dimitrovska
    Dijana Plaseska-Karanfilska
    Breast Cancer Research and Treatment, 2018, 168 : 745 - 753
  • [50] Management Strategies of Breast Cancer Patients with BRCA1 and BRCA2 Pathogenic Germline Variants
    Edaily, Sarah
    Abdel-Razeq, Hikmat
    ONCOTARGETS AND THERAPY, 2022, 15 : 815 - 826